Bristol-Myers Squibb Co. (NYSE: BMY)’s stock price has soared by 1.30 in relation to previous closing price of 48.30. Nevertheless, the company has seen a
The stock of Bristol-Myers Squibb Co. (BMY) has seen a -5.92% decrease in the past week, with a -8.30% drop in the past month, and
Bristol-Myers Squibb Co. (NYSE: BMY)’s stock price has dropped by -0.16 in relation to previous closing price of 51.40. Nevertheless, the company has seen a
Bristol-Myers Squibb Co. (NYSE: BMY) has a higher price-to-earnings ratio of 14.06x compared to its average ratio, The 36-month beta value for BMY is at
MyoKardia to attain $225 per share, a premium of 61% over the biotech stock’s Friday closing price. The biotech company, MyoKardia Inc. (MYKO) is set
© 2024, Fueled by Smart TechOne
